Clinical Trial Update: Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 clinical trial at the University of Jordan evaluating allogeneic Wharton jelly mesenchymal stromal cells for autism; recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Allogeneic Wharton Jelly Mesenchymal Cells (WJMSC) (Wharton jelly mesenchymal stromal cells)

Snippet

Sponsor: University of Jordan | Conditions: Autism | Phase 1 | Status: RECRUITING